Discovery of a First-in-Class Inhibitor of the PRMT5-Substrate Adaptor InteractionJOURNAL OF MEDICINAL CHEMISTRYIF6.82021-08-0334OA
Discovery and Early Clinical Development of LY3202626, a Low-Dose, CNS-Penetrant BACE InhibitorJOURNAL OF MEDICINAL CHEMISTRYIF6.82021-06-0314PREAI
Preparation and biological evaluation of BACE1 inhibitors: Leveraging trans-cyclopropyl moieties as ligand efficient conformational constraintsBIOORGANIC & MEDICINAL CHEMISTRYIF32020-01-0113PREAI
Optimization of Hydroxyethylamine Transition State Isosteres as Aspartic Protease Inhibitors by Exploiting Conformational PreferencesJOURNAL OF MEDICINAL CHEMISTRYIF6.82017-11-288PREAI
Preparation and biological evaluation of conformationally constrained BACE1 inhibitorsBIOORGANIC & MEDICINAL CHEMISTRYIF32015-07-0116OAAI
Structural and Functional Analysis of Two New Positive Allosteric Modulators of GluA2 Desensitization and DeactivationMOLECULAR PHARMACOLOGYIF32011-08-0140OAAI
Slow-onset inhibition of fumarylacetoacetate hydrolase by phosphinate mimics of the tetrahedral intermediate: kinetics, crystal structure and pharmacokineticsBIOCHEMICAL JOURNALIF4.32007-02-1216OAAI
Pyrithiamine as a substrate for thiamine pyrophosphokinaseJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92006-03-0150OAAI
Preorganization of the hydroxyethylene dipeptide isostere:: The preferred conformation in solution resembles the conformation bound to BACEJOURNAL OF MEDICINAL CHEMISTRYIF6.82005-11-028PREAI
Mechanistic inferences from the crystal structure of fumarylacetoacetate hydrolase with a bound phosphorus-based inhibitorsJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92001-01-0156OAAI
Structural and functional analysis of missense mutations in fumarylacetoacetate hydrolase, the gene deficient in hereditary tyrosinemia type 1JOURNAL OF BIOLOGICAL CHEMISTRYIF3.92001-01-0138OAAI
Structural and functional analysis of mutations in alkaptonuriaHUMAN MOLECULAR GENETICSIF3.22000-09-0178OAAI